Medicamentos para el tratamiento de la disfunción eréctil: ¿Qué es mejor, cuáles son las diferencias?
The use of vardenafil offers no protection against sexually transmitted diseases. Counseling of patients about protective measure necessary to guard against sexually transmitted diseases, including the Human Immunodeficiency Virus (HIV), should be considered. Advise patients that the disintegrating tablet (Staxyn) is not interchangeable with the film-coated tablet (Levitra).
What are the possible side effects of vardenafil?
Renal Impairment: In male volunteers with ClCr= 50-80 mL/min, the pharmacokinetics of vardenafil were similar to those observed in a control group with ClCr >80 mL/min. In male volunteers with ClCr = 30-50 mL/min or ClCr <30 mL/min renal impairment groups, the AUC of vardenafil was 20-30% higher compared to that observed in a control group with ClCr >80 mL/min). Vardenafil pharmacokinetics have not been evaluated in patients requiring renal dialysis. Advise patients of the contraindication of vardenafil with regular and/or intermittent use of organic nitrates. Patients should be counseled that concomitant use of vardenafil with nitrates could cause blood pressure to suddenly drop to an unsafe level, resulting in dizziness, syncope, or even heart attack or stroke.
Pulmonary Arterial Hypertension (Orphan)
Inform patients of the potential cardiac risk of sexual activity for patients with preexisting cardiovascular risk factors. Inform patients that in some patients concomitant use of PDE5 inhibitors, including vardenafil, with alpha-blockers can lower blood pressure significantly leading to symptomatic hypotension (for example, fainting). Patients prescribed vardenafil who are taking alpha-blockers should be started on the lowest recommended starting dose. Patients should be advised of the possible occurrence of symptoms related to postural hypotension and appropriate countermeasures. Patients should be advised to contact the prescribing physician if other anti-hypertensive drugs or new medications that may interact with vardenafil are prescribed by another healthcare provider. General Notes: May be taken with or without food. (Tablet) Place on tongue to disintegrate; take without liquid and immediately upon removal from blister.
| Ingredient | Concentration | Purpose | Notes |
|---|---|---|---|
| Vardenafil Hydrochloride | 20 mg/mL | Active component for erectile dysfunction relief | Prescribed dose varies |
| Glycerin | 10% | Solvent and base | Enhances absorption |
| Purified Water | Q.S. to 100% | Diluent | Ensures stability |
| Flavoring Agents | - | Improves taste | Commonly mint or berry |
Vardenafil is typically taken as needed before sexual activity, often starting at 10 mg per dose. It is available as a standard oral tablet or an orally disintegrating tablet (ODT). The medication usually begins working within 30-60 minutes, and sexual stimulation is required for it to be effective. Swallow standard tablets whole without crushing or chewing them. If you are using the ODT, place it on your tongue with dry hands, and allow it to dissolve completely without liquid. Always take vardenafil exactly as prescribed by your healthcare provider, and do not exceed the recommended dose. Certain substances and medications can interact with vardenafil. Avoid drinking grapefruit juice, which can affect how the medication is processed in your body.
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Levitra Original | 20mg | 14 + 2 Pills | 102.27€ 97.40€ | |
| Levitra Professional | 20mg | 60 + 2 Pills | 223.11€ 212.49€ | |
| Levitra Original | 20mg | 22 + 2 Pills | 138.55€ 131.95€ | |
| Levitra Generic | 20mg | 10 Pills | 31.49€ 29.99€ | |
| Levitra Soft Tabs | 20mg | 180 + 10 Pills | 398.14€ 379.18€ | |
| Levitra Generic | 40mg | 180 + 10 Pills | 405.06€ 385.77€ | |
| Levitra Soft Tabs | 20mg | 270 + 10 Pills | 521.78€ 496.93€ | |
| Levitra Generic | 60mg | 20 Pills | 81.30€ 77.43€ | |
| Levitra Generic | 20mg | 20 Pills | 52.63€ 50.12€ | |
| Levitra Professional | 20mg | 120 + 4 Pills | 348.44€ 331.85€ | |
| Levitra Generic | 20mg | 90 + 8 Pills | 180.78€ 172.17€ |
Alcohol may increase the risk of side effects such as dizziness or low blood pressure. Vardenafil should not be taken with nitrate medications, including nitroglycerin, isosorbide dinitrate, riociguat, or isosorbide mononitrate, because this combination can cause dangerously low blood pressure. Do not combine vardenafil with other ED medications.
5.10 Combination with Other Erectile Dysfunction Therapies
It is not possible to determine whether these events were related directly to the use of PDE5 inhibitors or to other factors. Inform patients of the increased risk of NAION in individuals who have already experienced NAION in one eye and discuss the increased risk of NAION among the general population in patients with a "crowded" optic disc, although evidence is insufficient to support screening of prospective users of PDE5 inhibitor, including vardenafil, for this uncommon condition. Advise patients to stop treatment and seek prompt medical attention in the event of sudden decrease or loss of hearing. These events, which may be accompanied by tinnitus and dizziness, have been reported in temporal association to the intake of PDE5 inhibitors, including vardenafil. It is not possible to determine whether these events are related directly to the use of PDE5 inhibitors or to other factors. Tell your healthcare provider if you take medications for high blood pressure, alpha-blockers, antifungal medications such as fluconazole, or other treatments for ED, as there may be drug interactions.
- Liquid Levitra should be measured with a proper device.
- Avoid mixing with hot liquids to prevent degradation.
- Keep the medication stored at room temperature.
You should also mention any supplements you use, especially St. John’s wort.
| Advantage | Explanation | Compared to Tablets |
|---|---|---|
| Quick Absorption | Liquid form is absorbed faster than tablets | Faster onset |
| Easier to Swallow | Suitable for individuals with swallowing difficulties | Better for some users |
| Dose Flexibility | Can be measured precisely | More adaptable dosing |
| Faster Effects | Effects seen sooner after intake | More immediate results |
Vardenafil may not be appropriate for people with certain heart conditions, Peyronie's disease, or those who are advised to avoid sexual activity.
- The medication is available by prescription only.
- Liquid form allows flexible dosing compared to tablets.
- Usage instructions should be followed exactly.
Always follow your provider’s guidance to ensure safe and effective use of the medication. New ED Formulation Puts Focus on Men’s Sexual Health as Part of Overall Wellness TAMPA — Jan. 28, 2026 — BoomRx, the fastest-growing national pharmaceutical technology platform that simplifies prescription sourcing and fulfillment, today announced the availability of a new oral liquid erectile dysfunction (ED) therapy that combines Viagra, Cialis and Levitra—offered as an alternative to conventional ED formulations currently on the market. Developed to support medical clinics and healthcare providers addressing men’s sexual health as part of comprehensive wellness care, the new offering combines sildenafil (Viagra), tadalafil (Cialis), and vardenafil (Levitra) into a single formulation using a nanoemulsion liquid delivery system.
5.4 Effects on the Eye
Absorption: Vardenafil is rapidly absorbed with absolute bioavailability of approximately 15%. Maximum observed plasma concentrations after a single 20 mg dose in healthy volunteers are usually reached between 30 minutes and 2 hours (median 60 minutes) after oral dosing in the fasted state. Two food-effect studies were conducted which showed that high-fat meals caused a reduction in Cmax by 18%-50%. Distribution: The mean steady-state volume of distribution (Vss) for vardenafil is 208 L, indicating extensive tissue distribution. Vardenafil and its major circulating metabolite, M1, are highly bound to plasma proteins (about 95% for parent drug and M1).
What are the serious side effects of vardenafil?
This protein binding is reversible and independent of total drug concentrations. Following a single oral dose of 20 mg vardenafil in healthy volunteers, a mean of 0.00018% of the administered dose was obtained in semen 1.5 hours after dosing. Metabolism: Vardenafil is metabolized predominantly by the hepatic enzyme CYP3A4, with contribution from the CYP3A5 and CYP2C isoforms. The major circulating metabolite, M1, results from desethylation at the piperazine moiety of vardenafil. The plasma concentration of M1 is approximately 26% that of the parent compound. All three active ingredients are phosphodiesterase-5 (PDE5) inhibitors, a well-established class of medications used to treat ED by relaxing blood vessels and increasing blood flow to the penis.
La DE es tratable en Casi Todos los Hombres
This metabolite shows a phosphodiesterase selectivity profile similar to that of vardenafil and an in vitro inhibitory potency for PDE5 28% of that of vardenafil. Therefore, M1 accounts for approximately 7% of total pharmacologic activity. Elimination: The total body clearance of vardenafil is 56 L/h, and the terminal half-life of vardenafil and its primary metabolite (M1) is approximately 4-5 hours. After oral administration, vardenafil is excreted as metabolites predominantly in the feces (approximately 91-95% of administered oral dose) and to a lesser extent in the urine (approximately 2-6% of administered oral dose). Pediatrics: Vardenafil is not indicated for use in pediatric patients.
Psychological conditions
Vardenafil trials were not conducted in the pediatric population. Geriatric: In a healthy volunteer study of elderly males (≥65 years) and younger males (18-45 years), mean Cmax and AUC were 34% and 52% higher, respectively, in the elderly males. Hepatic Impairment: In volunteers with mild hepatic impairment (Child-Pugh A), the Cmax and AUC following a 10 mg vardenafil dose were increased by 22% and 17%, respectively, compared to healthy control subjects. In volunteers with moderate hepatic impairment (Child- Pugh B), the Cmax and AUC following a 10 mg vardenafil dose were increased by 130% and 160%, respectively, compared to healthy control subjects. Vardenafil has not been evaluated in patients with severe (Child-Pugh C) hepatic impairment. By combining these agents into a single liquid formulation, BoomRx expands therapeutic options available to providers seeking flexibility, consistency, and alternative delivery formats for more individualized treatment plans.
2.4 Concomitant Medications
Discuss with patients the appropriate use of vardenafil and its anticipated benefits. It should be explained that sexual stimulation is required for an erection to occur after taking vardenafil. It should be taken approximately 60 minutes before sexual activity. Patients should be counseled regarding the dosing of vardenafil especially regarding the maximum daily dose. Patients should be advised to contact their healthcare provider levitra shipping for dose modification if they are not satisfied with the quality of their sexual performance with vardenafil or in the case of an unwanted effect.
Warnings While Using This Medicine:
Inform patients that there have been rare reports of prolonged erections greater than 4 hours and priapism (painful erections greater than 6 hours in duration) for vardenafil and this class of compounds. In the event that an erection persists longer than 4 hours, the patient should seek immediate medical assistance. If priapism is not treated immediately, penile tissue damage and permanent loss of potency may result. Advise patients to stop treatment and seek medical attention in the event of sudden loss of vision in one or both eyes. Such an event may be a sign of non-arteritic anterior ischemic optic neuropathy (NAION), a cause of decreased vision, including permanent loss of vision, that has been reported rarely post-marketing in temporal association with the use of all PDE5 inhibitors. Existing ED therapies are commonly delivered through tablets, capsules, gels, creams, transdermal patches and injectables. While effective for many patients, these formats may present challenges related to absorption variability, onset timing, or patient adherence.